FLOW PHARMA, INC.

Profile

Company Names

FLOW PHARMA, INC.

Addresses

4829 GALAXY PARKWAY, SUITE K, WARRENSVILLE HEIGHTS, OH 44128

45 QUAIL COURT 300, WALNUT CREEK, CA 94596

Phone Numbers

1-216-350-8361
4152382300

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$3,814,710.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2024-07-31 
$225,000.00 
$40,000,000.00 
$39,775,000.00 
Equity 
3
2022-10-20 
$180,000.00 
$10,500,000.00 
$10,320,000.00 
Equity 
2
2016-03-21 
$2,260,000.00 
INDEFINITE 
INDEFINITE 
Debt 
1
2011-04-29 
$1,149,710.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
THOMAS 
 
BARNISH 
EXECUTIVE OFFICER
TIKOES 
 
BLANKENBERG 
DIRECTOR
TOM 
 
BRADY 
EXECUTIVE OFFICER
STEPHEN 
 
FARR 
DIRECTOR
CHARLES 
VINCENT 
HERST 
EXECUTIVE OFFICER
LESTER 
LLOYD 
EXECUTIVE OFFICER, DIRECTOR
LESTER 
JOHN 
LLOYD 
EXECUTIVE OFFICER, DIRECTOR
BABATUNDE 
 
OTULANA 
DIRECTOR
REID 
RUBSAMEN 
EXECUTIVE OFFICER, DIRECTOR
REID 
MARTIN 
RUBSAMEN 
EXECUTIVE OFFICER, DIRECTOR
REID 
MICHAEL 
RUBSAMEN 
EXECUTIVE OFFICER, DIRECTOR
PAMELA 
 
STEELE 
DIRECTOR
ANTHONY 
 
TUFARO 
DIRECTOR
GIL 
 
VAN BOKKELEN 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-10-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-03-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
CARLETON MCKENNA ADVISORS, LLC